Researchers explored the risks for basal cell carcinoma, squamous cell carcinoma, and melanoma in patients who underwent BMT.

A key feature of cutaneous inflammatory diseases is the infiltration of myeloid cells into the skin. However, the role and crosstalk of subpopulations of myeloid cells, their interaction and the role ...

Acute myeloid leukemia (AML) is a cancer that affects bone ... The post Prayers For Baby Girl Born with Pale Purple Spots on ...

Atezolizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase I for Refractory Acute Myeloid Leukemia.

Vevoctadekin is under clinical development by Simcha Therapeutics and currently in Phase I for Refractory Acute Myeloid Leukemia.